Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis

MLA

Moore, Hillary, et al. “Post-Induction Infliximab Trough Levels and Disease Activity in the Clinical Evolution of Pediatric Ulcerative Colitis.” United European Gastroenterology Journal, vol. 8, no. 4, May 2020, pp. 425–35. EBSCOhost, https://doi.org/10.1177/2050640620912877.

APA

Moore, H., Dolce, P., Devas, N., Baldassano, R., & Martinelli, M. (2020). Post-induction infliximab trough levels and disease activity in the clinical evolution of pediatric ulcerative colitis. United European Gastroenterology Journal, 8(4), 425–435. https://doi.org/10.1177/2050640620912877

Chicago

Moore, Hillary, Pasquale Dolce, Nina Devas, Robert Baldassano, and Massimo Martinelli. 2020. “Post-Induction Infliximab Trough Levels and Disease Activity in the Clinical Evolution of Pediatric Ulcerative Colitis.” United European Gastroenterology Journal 8 (4): 425–35. doi:10.1177/2050640620912877.